Chronos Therapeutics Limited
Chronos Therapeutics is focused on drug development through discovery and repositioning FDA/EMA approved drugs
Location: Oxford
Sector: Pharmaceutical
Date appointed: October 2014
Services Provided:
Chronos Therapeutics is focused on novel drug discovery and rapid drug development. Proprietary positions in the regulation of cellular chronological lifespan allows Chronos’ research to be advanced into pre-clinical stages of development for age-related diseases quickly and efficiently.
Mark Donaldson was appointed as Finance Director in October 2014, providing financial oversight, budgeting, management accounts and forecasting.
